Camber releases generic Xeloda
Capecitabine is a nucleoside metabolic inhibitor indicated for the treatment of several cancers.
Camber is offering capecitabine tablets, which is a generic of Xeloda.
Capecitabine is a nucleoside metabolic inhibitor indicated for the treatment of several cancers, including: colorectal cancer, breast cancer, gastric, esophageal, gastroesophageal junction and pancreatic cancer.
[Read more: Camber rolls out generic Stendra]
Camber’s capecitabine tablets are available in the following strengths and packaging options: 150 mg, 60-count bottles; 500 mg, 60-count and 120-count bottles.